Fresenius SE & Co. KGaA Stock Other OTC
Equities
FSNUY
US35804M1053
Healthcare Facilities & Services
Sales 2024 * | 23.02B 24.58B | Sales 2025 * | 24.04B 25.67B | Capitalization | 14.93B 15.94B |
---|---|---|---|---|---|
Net income 2024 * | 1.42B 1.52B | Net income 2025 * | 1.77B 1.89B | EV / Sales 2024 * | 1.32 x |
Net Debt 2024 * | 15.48B 16.52B | Net Debt 2025 * | 14.81B 15.81B | EV / Sales 2025 * | 1.24 x |
P/E ratio 2024 * |
10.3
x | P/E ratio 2025 * |
8.37
x | Employees | - |
Yield 2024 * |
3.51% | Yield 2025 * |
4% | Free-Float | 73.04% |
Latest transcript on Fresenius SE & Co. KGaA
Managers | Title | Age | Since |
---|---|---|---|
Michael Sen
CEO | Chief Executive Officer | 55 | 21-04-11 |
Sara Hennicken
DFI | Director of Finance/CFO | 44 | 18-12-31 |
Michael Moser
CMP | Compliance Officer | - | 23-07-17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Diekmann
BRD | Director/Board Member | 69 | 15-05-19 |
Wolfgang Kirsch
CHM | Chairman | 69 | 19-12-31 |
Konrad Kölbl
BRD | Director/Board Member | 64 | 07-07-15 |
1st Jan change | Capi. | |
---|---|---|
+14.91% | 82.27B | |
+11.06% | 29.43B | |
-12.02% | 16.82B | |
-7.91% | 14.1B | |
+1.32% | 12.05B | |
-30.18% | 12.01B | |
+21.84% | 11.19B | |
-5.48% | 11.09B | |
+44.20% | 10.91B |